← Back
$CORT All transactions

CORCEPT THERAPEUTICS INC

▼ SELL 10b5-1 Plan

$ Value

$50K

Shares

700

Price

$71

Filed

Sep 4

Insider

Name

BELANOFF JOSEPH K

Title

Chief Executive Officer

CIK

0001286199

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-02

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

2,821,370

Footnotes

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction. | Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $69.97 to $70.96 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. | Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. | Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $70.97 to $71.085 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Filing Info

Accession No.

0001193125-25-196313

Form Type

4

Issuer CIK

0001088856

BELANOFF JOSEPH K's History

Date Ticker Type Value
2026-03-25 CORT $1.3M
2025-12-24 CORT M $2.1M
2025-12-24 CORT F $25.6M
2025-12-24 CORT G $0
2025-12-24 CORT J $0
2025-12-24 CORT M $0
2025-12-01 CORT $3.2M
2025-11-05 CORT $1.1M
2025-11-05 CORT $814K
2025-11-05 CORT $273K

Other Insiders at CORT (90d)

Insider Bought Sold Last
BAKER G LEONARD JR 2026-01-27
WILSON JAMES N 2026-04-06
BELANOFF JOSEPH K
Chief Executive Officer
$1.3M 2026-03-25
Hunt Hazel
Chief Scientific Officer
2026-02-09
Guyer William
Chief Development Officer
$2.1M 2026-04-07